製剤開発アウトソーシング市場規模、シェア、動向分析レポート：サービス別、製剤別、治療領域別、最終用途別、地域別、セグメント予測、2025年～2030年

製剤開発アウトソーシング市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の製剤開発アウトソーシング市場規模は2030年までに606億6,000万米ドルに達し、2025～2030年のCAGRは8.62%を記録すると推定されています。

慢性疾患や感染症への高い負担、難溶性薬剤のバイオアベイラビリティ改善への関心の高まり、薬剤開発に伴う合併症などが、製剤開発サービスの世界の需要に寄与しています。さらに、COVID-19の大流行は、伝染性ウイルスに対する効果的な治療法を見つけるための臨床検査の必要性に影響を及ぼしています。このため、治療を開発するための研究開発（R&D）に多額の投資が行われており、これが市場を牽引すると予想されています。

Pharma R&D Annual Review 2022によると、2022年に開発段階にある主要医薬品はバイオ医薬品と抗がん剤であり、これによりパンデミック後のこれらの医薬品の製剤開発需要が向上すると予想されます。世界的に、製薬会社は研究開発活動に大きく貢献しています。例えば、Merck社の研究開発費は、2019年の24億9,480万米ドルに対し、2020年は25億1,680万米ドルでした。同様に、バイオジェンの研究開発費は2020年に39億9,090万米ドルを占めました。同社の研究開発費は2019年と比較して75%増加しました。研究開発費の大幅な増加は、市場にプラスの影響を与えそうです。

製剤開発に伴う合併症により、後期臨床検査に至らない医薬品は相当数に上ります。さらに、医薬品の開発に関する厳しい規制が、製剤開発のアウトソーシング需要をさらに高めています。このような要因により、需要の向上が期待されます。COVID-19の発症率は、世界のワクチン接種の活発化により大幅に減少しています。その結果、CROやCDMOは再びがんやその他の疾患の医薬品開発に注力しています。例えば、2022年4月、LabcorpはXcell Biosciencesと提携し、同社ががん、パーキンソン病、その他の希少疾患を治療するための細胞・遺伝子治療の開発を行うことを支援しました。CDMOのこうした取り組みは、がんやその他の希少疾患の治療に使用される医薬品の製剤開発アウトソーシング需要を促進するとみられます。

製剤開発アウトソーシング市場レポートハイライト

• サービス別では、プレフォーミュレーション部門が予測期間中に最も速いCAGRで成長すると予測されます。
• 製剤部門では、予測期間中に大幅なCAGR成長が見込まれます。
• 治療領域別では、がん領域が2024年に最大の市場収益シェアを占めました。
• アジア太平洋は、コスト効率の高い製剤開発サービスを提供するCROが多数存在することから、2024年に最大の収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 製剤開発アウトソーシング市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 臨床検査件数分析（2024年）
  • 地域別臨床検査総数
  • 臨床検査の総数（相別）
  • 臨床検査の総数（研究デザイン別）
  • 主要治療領域別臨床検査総数
• 価格モデル分析
• 技術
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 製剤開発アウトソーシング市場：サービス別、推定・動向分析

• 製剤開発アウトソーシング市場（サービス別）：セグメントダッシュボード
• 製剤開発アウトソーシング市場（サービス別）：変動分析
• サービス別、2018～2030年
• 配合前
• 配合開発

第5章 配合開発アウトソーシング市場：製剤別、推定・動向分析

• 配合開発アウトソーシング市場（製剤別）：セグメントダッシュボード
• 配合開発アウトソーシング市場（製剤別）：変動分析
• 製剤別、2018～2030年
• 経口
• 注射剤
• 局所
• その他

第6章 製剤開発アウトソーシング市場：治療領域別、推定・動向分析

• 製剤開発アウトソーシング市場（治療領域別）：セグメントダッシュボード
• 製剤開発アウトソーシング市場（治療領域別）：変動分析
• 治療領域別、2018～2030年
• 腫瘍学
• 感染症
• 神経学
• 血液学
• 呼吸器
• 心血管系
• 皮膚科
• その他

第7章 製剤開発アウトソーシング市場：最終用途別、推定・動向分析

• 製剤開発アウトソーシング市場（最終用途別）：セグメントダッシュボード
• 製剤開発アウトソーシング市場（最終用途別）：変動分析
• 最終用途別、2018～2030年
• 製薬会社とバイオ医薬品会社
• 政府機関と学術機関
• その他

第8章 製剤開発アウトソーシング市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • オランダ
  • スイス
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • インドネシア
  • マレーシア
  • シンガポール
  • タイ
  • 台湾
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • コロンビア
  • チリ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト
  • イスラエル
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 企業市場シェア/評価分析、2024年
• 企業プロファイル
  • SGS SA
  • Intertek Group plc
  • Recipharm
  • Lonza
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Element
  • Labcorp
  • Thermo Fisher Scientific, Inc.
  • Catalent Inc.

第10章 主要推奨事項

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 4 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 5 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 6 Global Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 7 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 10 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 11 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 12 North America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 14 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 15 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 16 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 18 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 19 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 20 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 22 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 23 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 24 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 27 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 28 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 29 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 30 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 31 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 32 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 33 UK Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 34 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 35 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 36 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 37 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 38 France Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 39 France Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 40 France Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 41 France Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 43 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 44 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 45 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 47 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 48 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 49 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 50 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 51 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 52 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 53 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 54 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 55 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 56 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 57 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 58 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 59 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 60 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 61 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 62 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 63 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 64 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 65 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 66 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 67 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 68 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 69 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 75 China Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 76 China Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 77 China Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 78 China Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 79 India Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 80 India Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 81 India Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 82 India Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 83 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 84 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 85 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 86 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 87 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 88 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 89 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 90 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 91 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 92 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 93 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 94 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 95 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 96 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 97 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 98 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 99 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 100 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 101 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 102 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 103 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 104 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 105 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 106 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 107 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 108 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 109 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 110 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 111 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 112 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 113 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 114 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 115 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 116 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 117 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 118 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 119 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 120 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 121 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 122 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 123 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 124 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 125 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 126 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 127 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 128 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 129 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 130 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 131 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 132 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 133 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 134 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 135 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 136 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 137 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 138 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 139 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 140 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 141 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 142 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 143 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 144 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 145 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 146 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 147 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 148 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 149 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 150 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 151 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 152 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 153 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 154 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 155 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 156 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 157 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 158 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 159 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 160 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 161 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
• Table 162 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
• Table 163 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 164 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Formulation Development Outsourcing Market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Formulation Development Outsourcing Market: Service outlook and key takeaways
• Fig. 20 Formulation Development Outsourcing Market: Service movement analysis
• Fig. 21 Preformulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Formulation Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Formulation Development Outsourcing Market: Formulation outlook and key takeaways
• Fig. 24 Formulation Development Outsourcing Market: Formulation movement analysis
• Fig. 25 Oral Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Injectable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Topical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Formulation Development Outsourcing Market: Therapeutic Area outlook and key takeaways
• Fig. 30 Formulation Development Outsourcing Market: Therapeutic Area Movement Analysis
• Fig. 31 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Respiratory Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Formulation Development Outsourcing Market: End Use outlook and key takeaways
• Fig. 40 Formulation Development Outsourcing Market: End Use movement analysis
• Fig. 41 Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Government and Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Regional Marketplace: Key Takeaways
• Fig. 45 North America Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Canada Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Europe Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 UK Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Germany Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 France Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Italy Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Spain Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Norway Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 China Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 India Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Japan Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Australia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Key country dynamics
• Fig. 98 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key country dynamics
• Fig. 100 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Key country dynamics
• Fig. 102 Chile Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 103 MEA Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Key country dynamics
• Fig. 107 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Key country dynamics
• Fig. 109 UAE Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Key country dynamics
• Fig. 111 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 112 Key country dynamics
• Fig. 113 Israel Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 114 Key country dynamics
• Fig. 115 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 116 Key company categorization
• Fig. 117 Service heat map analysis
• Fig. 118 Strategic framework

Formulation Development Outsourcing Market Growth & Trends:

The global formulation development outsourcing market size is estimated to reach USD 60.66 billion by 2030, registering a CAGR of 8.62% from 2025 to 2030, according to a new report by Grand View Research, Inc. The high burden of chronic and infectious diseases, the growing focus on improving the bioavailability of poorly soluble drugs, and the complications associated with drug development are contributing to the demand for formulation development services globally. Furthermore, the COVID-19 outbreak has influenced the need for clinical trials to find an effective treatment against the contagious virus. This has resulted in significant investments in research and development (R&D) to develop therapeutics, which are expected to drive the market.

According to Pharma R&D Annual Review 2022, biopharmaceutical and anticancer drugs are the major drugs in the development stage in the year 2022, this is expected to improve the demand for formulation development of these drugs post-pandemic. Globally, the pharmaceutical companies are making significant contributions to R&D activities. For instance, Merck's R&D cost was USD 2,516.8 million in 2020 as compared to USD 2,494.8 million in 2019. Similarly, Biogen's R&D expenses accounted for USD 3,990.9 million in 2020. The company's R&D expenditure increased by 75% as compared to 2019. The significant increase in R&D expenditure is likely to have a positive impact on the market.

A significant number of drugs fail to reach late-stage clinical trials owing to complications associated with formulation development. Moreover, strict regulations regarding the development of drugs are further contributing to the demand for outsourcing formulation development. Such factors are expected to improve the demand. The COVID-19 incidence has been significantly reduced owing to the growing vaccination drive globally. As a result, the CRO and CDMO are once again concentrating on the development of drugs for oncology and other disorders. For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson's disease, and other rare diseases. Such initiatives by the CDMOs are likely to promote the demand for the formulation development outsourcing of drugs used in the treatment of cancer and other rare diseases.

Formulation Development Outsourcing Market Report Highlights:

• Based on services, the preformulation segment is expected to grow at the fastest CAGR during the forecast period.
• Based on formulation, the drug product segment is expected to grow at a significant CAGR during the forecast period.
• Based on therapeutic area, the oncology segment accounted for the largest market revenue share in 2024.
• Asia Pacific held the largest revenue share in 2024, due to the presence of a significant number of CROs providing cost effective formulation development services.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Formulation
  • 1.2.3. Therapeutic Area
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Formulation Development Outsourcing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Clinical Trials Volume Analysis, (2024)
  • 3.3.1. Total Number of Clinical Trials By Region
  • 3.3.2. Total Number of Clinical Trials, By Phase
  • 3.3.3. Total Number of Clinical Trials, By Study Design
  • 3.3.4. Total Number of Clinical Trials, By Key Therapeutic Area
• 3.4. Pricing Model Analysis
• 3.5. Technology Landscape
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Force Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Formulation Development Outsourcing Market: Service Estimates & Trend Analysis

• 4.1. Formulation Development Outsourcing Market, By Service: Segment Dashboard
• 4.2. Formulation Development Outsourcing Market, By Service: Movement Analysis
• 4.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Preformulation
  • 4.4.1. Preformulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Formulation Development
  • 4.5.1. Formulation Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Formulation Development Outsourcing Market: Formulation Estimates & Trend Analysis

• 5.1. Formulation Development Outsourcing Market, By Formulation: Segment Dashboard
• 5.2. Formulation Development Outsourcing Market, By Formulation: Movement Analysis
• 5.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Formulation, 2018 - 2030
• 5.4. Oral
  • 5.4.1. Oral Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Injectable
  • 5.5.1. Injectable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Topical
  • 5.6.1. Topical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Formulation Development Outsourcing Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Formulation Development Outsourcing Market, By Therapeutic Area: Segment Dashboard
• 6.2. Formulation Development Outsourcing Market, By Therapeutic Area: Movement Analysis
• 6.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
• 6.4. Oncology
  • 6.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Infectious Disease
  • 6.5.1. Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Neurology
  • 6.6.1. Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Hematology
  • 6.7.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Respiratory
  • 6.8.1. Respiratory Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Cardiovascular
  • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. Dermatology
  • 6.10.1. Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Others
  • 6.11.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Formulation Development Outsourcing Market: End Use Estimates & Trend Analysis

• 7.1. Formulation Development Outsourcing Market, By End Use: Segment Dashboard
• 7.2. Formulation Development Outsourcing Market, By End Use: Movement Analysis
• 7.3. Formulation Development Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
• 7.4. Pharmaceutical and Biopharmaceutical Companies
  • 7.4.1. Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Government and Academic Institutes
  • 7.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Formulation Development Outsourcing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Netherlands
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Switzerland
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Sweden
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Denmark
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Norway
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Japan
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Indonesia
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Indonesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.8. Malaysia
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.9. Singapore
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Competitive Scenario
    • 8.6.9.3. Regulatory Framework
    • 8.6.9.4. Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.10. Thailand
    • 8.6.10.1. Key Country Dynamics
    • 8.6.10.2. Competitive Scenario
    • 8.6.10.3. Regulatory Framework
    • 8.6.10.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.11. Taiwan
    • 8.6.11.1. Key Country Dynamics
    • 8.6.11.2. Competitive Scenario
    • 8.6.11.3. Regulatory Framework
    • 8.6.11.4. Taiwan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. Colombia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Chile
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Egypt
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Egypt Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.6. Israel
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Scenario
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.7. Kuwait
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Competitive Scenario
    • 8.8.7.3. Regulatory Framework
    • 8.8.7.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Share/Assessment Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. SGS S.A.
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Intertek Group plc
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Recipharm
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Lonza
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Charles River Laboratories International, Inc.
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Eurofins Scientific SE
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Element
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Labcorp
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Thermo Fisher Scientific, Inc.
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Catalent Inc.
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives

Chapter 10. Key Recommendations